Literature DB >> 11142448

Reemergence of insulin pump therapy in the 1990s.

L R Reynolds1.   

Abstract

The publication of the landmark Diabetes Control and Complications Trial results in 1993 provided a strong impetus to achieve near-normalization of blood glucose levels in type I diabetic patients using intensive insulin therapy programs. Recent studies show less hypoglycemia with this form of intensive therapy and equivalent or improved glycemic control. Insulin pump therapy is achieving wider acceptance and application in diabetes management. This commentary reviews the current status of insulin pump therapy, including indications and future directions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11142448

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

1.  Combined insulin pump therapy with real-time continuous glucose monitoring significantly improves glycemic control compared to multiple daily injection therapy in pump naïve patients with type 1 diabetes; single center pilot study experience.

Authors:  Scott W Lee; Tom Sweeney; Debbie Clausen; Celia Kolbach; Allen Hassen; Anthony Firek; Charles Brinegar; Jerrold Petrofsky
Journal:  J Diabetes Sci Technol       Date:  2007-05

2.  Consequences of delayed pump infusion line change in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion.

Authors:  Tina K Thethi; Ajay Rao; Haytham Kawji; Tilak Mallik; C Lillian Yau; Uwe Christians; Vivian Fonseca
Journal:  J Diabetes Complications       Date:  2009-04-23       Impact factor: 2.852

3.  Comparison of continuous subcutaneous insulin infusion and insulin glargine-based multiple daily insulin aspart injections with preferential adjustment of basal insulin in patients with type 2 diabetes.

Authors:  Guan-Qi Gao; Xue-Yuan Heng; Yue-Li Wang; Wen-Xia Li; Qing-Yu Dong; Cui-Ge Liang; Wen-Hua DU; Xiao-Meng Liu
Journal:  Exp Ther Med       Date:  2014-07-29       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.